Hong, J. H., Lim, A. H., Kaewnarin, K., Chan, J. Y., Ng, C. C. Y., & Teh, B. T. (2024). Biodiversity Medicine: New Horizon and New Opportunity for Cancer. Cancer Discovery, 14(3), 392–395. https://doi.org/10.1158/2159-8290.cd-23-1585
Abstract:
Accessibility to standard of care remains a challenge to patients in low- and middle-income countries (LMIC), hampering efforts to alleviate the burden of cancer and to improve overall health outcomes. In response to this pressing global health care issue, we propose here a new strategy to create affordable, easily accessible, and effective therapeutic solutions to address this inequity in cancer treatment: the use of science-based biodiversity medicine as an alternative to modern drug therapy, in which we will leverage and combine high-throughput omics technologies with artificial intelligence, to study local biodiversity, their potential anticancer properties, and short- and long-term clinical response and outcomes.
License type:
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Funding Info:
This research is supported by the Verdant Foundation